Logo

Qiagen: Jan 25, 2007

Jan 25, 2007
Premium
Qiagen has introduced the rat druggable genome siRNA set, a collection of siRNAs targeting roughly 6,000 rat genes corresponding to human genes of therapeutic potential.
According to the company, the siRNAs are provided either individually or in pools. Subsets targeting 426 GPCR genes, 738 kinase genes, or 198 phosphatase genes are also available.

Filed under

Gene Silencing/Gene Editing
RNAi
Breaking News
The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.